Andrea Garcia, JD, on new Omicron data and Pfizer COVID pill | COVID-19 Update for Dec. 15, 2021
AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering an increase in COVID cases as the U.S. surpassed 50 million on Monday, new data from a major study released by South Africa’s largest health insurer on vaccine efficacy against Omicron, and an update on Pfizer's COVID pill. 0:00 AMA COVID-19 Update for December 15, 2021 0:40 COVID-19 case count—as the total number of known COVID cases in the U.S. surpassed 50 million on Monday 1:39 Where are cases increasing the most across the country right now? 2:28 Current numbers regarding COVID-19 hospitalizations and deaths 3:39 Have we seen any patterns with these deaths; are they concentrated in particular regions in the U.S.? 4:25 How many people are vaccinated against COVID-19 in the U.S.? 5:43 Highlight eligibility for the Pfizer booster expanding to include 16- and 17-year-olds 6:36 What's the latest news on the Omicron variant? 7:43 Details from study showing Pfizer vaccine provided 70% protection in fully vaccinated individuals against severe disease from Omicron variant 8:46 New study data on COVID infections in children in South Africa 9:29 Does this data strengthen the case for boosters? 11:01 How quickly is the Omicron variant spreading in the U.S.? 11:56 Share details about Pfizer's COVID pill Stay up to date on the latest information about the pandemic: https://ama-assn.org/covid-19-resources. Visit the COVID-19 Daily Video Updates page for more videos in this series: https://ama-assn.org/covid-19-videos.
